Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature Discovery to co-host Predictive Toxicology in Discovery DMPK conference

Private equity-backed Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, is to co-host a symposium in Predictive Toxicology in Discovery DMPK at BioCity Nottingham on 22nd March 2018.

This one-day meeting will provide a forum for the exchange of ideas between members of the DMPK and toxicology research communities. Talks from thought leaders in industry and academia will provide global perspectives on how predictive toxicology platforms have evolved and became key to the drug discovery and development process. A range of ‘hot topics’ will be discussed, with a key theme being the central importance of understanding and harnessing underpinning toxicology concepts. The emphasis will be on building dialogue between participants, who will range from experienced project/laboratory leaders to early-career researchers from industry and academic institutions. The meeting will offer a variety of talks complemented by short oral presentations and poster presentations, as well as plenty of opportunities for networking throughout.

To register for this event, just click here.  Registration is free for DMDG members.

Latest News

View All

Sygnature Discovery moves US base to Kendall…

Sygnature Discovery raises over £2,776 for Cancer…

Sygnature Discovery named as Finalist in 2019…

Hidden chemistry in flowers shown to kill…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.